Literature DB >> 10614856

Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection.

L Kaiser1, M S Briones, F G Hayden.   

Abstract

BACKGROUND: Few data exist to assess the sensitivity of different specimen types for viral detection during the course of influenza virus infection.
OBJECTIVES: This study assessed the relationships between quantitative influenza A virus replication and antigen detectability by the enzyme immunosorbent assay (EIA) Directigen Flu A in different type of samples during experimental human infection. STUDY
DESIGN: Fourteen volunteers were inoculated with influenza A virus A/Texas/36/91 (H1N1). Four specimens types were collected in sequence for quantitative isolation in cell culture and antigen testing from days 1 to 8 after inoculation.
RESULTS: Seventy-one (63%) of nasopharyngeal wash specimens were culture positive, compared to 51 (46%) of throat gargles, 51 (46%) of nasal swabs, and 27 (24%) of throat swabs. All subjects shed virus in their nasopharyngeal wash at least one day and 86% of subjects had a positive nasopharyngeal wash culture on day 2 after inoculation. The mean viral titers were highest on day 2 post inoculation for all specimen types and averaged 3.6 log10 TCID50/ml for nasal washes, 1.2 log10 TCID50/ml for throat gargles, 1.8 log10 TCID50/ml for the nasopharyngeal swabs, and 0.6 log10 TCID50/ml for the throat swabs. Mean viral titers in the nasal washes were significantly different (P<0.05) compared to other specimen types. The peak of sensitivity of EIA (compared to culture) was the second day after inoculation. Nasopharyngeal and throat swab results were combined for this analysis and considered positive by culture if positive in either or both samples. Thus, on day 2 the number of EIA positive samples relative to the number culture positive was 9/12 (75%) for nasopharyngeal wash specimens, 2/9 (22%) for throat gargles, and 7/11 (64%) for the combined throat and nasal swabs specimens.
CONCLUSIONS: Nasopharyngeal washes are the most sensitive sample type detecting influenza A virus in adults. For rapid diagnosis the Directigen Flu A is an alternative with a sensitivity compared to culture ranging between 64 and 78% if performed on nasopharyngeal specimens on day two or three after experimental infection in adults. However, if performed on other specimens or later in the course of infection the sensitivity is lower.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614856     DOI: 10.1016/s1386-6532(99)00058-x

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  41 in total

1.  QuickVue influenza test for rapid detection of influenza A and B viruses in a pediatric population.

Authors:  Caroline Quach; Diane Newby; Ghislaine Daoust; Earl Rubin; Jane McDonald
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Clinical evaluation of the ZstatFlu-II test: a chemiluminescent rapid diagnostic test for influenza virus.

Authors:  Marilyn S Hamilton; David M Abel; Yolanda J Ballam; Mary K Otto; Angela F Nickell; Lisa M Pence; James R Appleman; Craig D Shimasaki; Komandoor E Achyuthan
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

3.  Evaluation of a new dot blot enzyme immunoassay (directigen flu A+B) for simultaneous and differential detection of influenza a and B virus antigens from respiratory samples.

Authors:  Jordi Reina; Emma Padilla; Fermin Alonso; Enrique Ruiz De Gopegui; Maria Munar; Margarita Mari
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

Review 4.  The role of rapid antigen testing for influenza in the era of molecular diagnostics.

Authors:  Suzanne E Dale
Journal:  Mol Diagn Ther       Date:  2010-08-01       Impact factor: 4.074

5.  Complementary monoclonal antibody-based dot ELISA for universal detection of H5 avian influenza virus.

Authors:  Fang He; Retno D Soejoedono; Sri Murtini; Michael Goutama; Jimmy Kwang
Journal:  BMC Microbiol       Date:  2010-12-30       Impact factor: 3.605

6.  Rapid Tests for Influenza.

Authors:  Constance T Pachucki
Journal:  Curr Infect Dis Rep       Date:  2005-05       Impact factor: 3.725

7.  Comparison of the Binax NOW Flu A enzyme immunochromatographic assay and R-Mix shell vial culture for the 2003-2004 influenza season.

Authors:  Robert C Fader
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

8.  Performance of rapid tests for detection of avian influenza A virus types H5N1 and H9N2.

Authors:  Daniel P Fedorko; Nancy A Nelson; Josephine M McAuliffe; Kanta Subbarao
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

9.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

Review 10.  How I treat influenza in patients with hematologic malignancies.

Authors:  Corey Casper; Janet Englund; Michael Boeckh
Journal:  Blood       Date:  2009-12-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.